Multiple Sclerosis Resource Centre
  • Home
  • MSRC Grand Opening 30/05/12
  • About MS
  • MSRC Services
  • Get Involved
  • MS Research News
  • MSRC Groups
  • Useful Resources
  • Welcome To Josephs Court, MS Centre Of Excellence
  • Advertising
  • Best Bet Diet Group
  • E-Newsletter
  • Contact Us
  • Investor in People
    You are here : Home » MS Research News » New Discoveries » Pesticides and Multiple Sclerosis

    Pesticides and Multiple Sclerosis

    A A A
    [Print this page]

    Share |


    Research suggests link between pesticides and brain disease
    Researchers at the University of North Dakota say preliminary research shows a link between pesticide exposure and neurological diseases like Parkinsons and Alzheimers. Researchers say they've also identified a surprisingly efficient way pesticides may get into the human body.

    Researchers at the University of North Dakota are quick to point out these are preliminary results -- covering one year of a planned four-year study.

    But Dr. Patrick Carr says there's clear evidence pesticide exposure at relatively low doses affect brain cells.

    "Some areas of the brain displayed what I would call physical changes -- in other words, a loss of neurons in particular regions of the brain," says Carr. "In other regions of the brain you wouldn't notice a change in the number of cells present there, but now the cells that are present there are expressing chemicals in different amounts, compared to normal rats."

    As an example, Carr found cells responsible for production of a substance called myelin were damaged or destroyed. Myelin is a substance made up of fats and proteins that encloses nerves. It helps transmit signals along the nerves. Loss of myelin causes nerve damage in neurological diseases such as multiple sclerosis.

    Researchers studied six common pesticides. Carr says some rats were given a single large dose, while others were injected with small doses over a nine-month period.

    "It's hard to then correlate that to what the average person that's working with pesticides would be exposed to," says Carr. "We're not at that position yet, where we can say this is comparable to what these people working with pesticides, short term or long term, are exposed to."

    Dr. Carr hopes to have his results completely analysed by next spring.

    Gerald Groenwald, director of energy and environmental research, says there's clearly a need to continue and expand the research.

    "What this research says is that we have started to open some doors and shine some light in a very objective fashion, a very comprehensive fashion, on this group of questions," says Groenwald. "And it says, more than ever, that this research is extremely important not only here in the Red River Valley, but basically globally."

    Groenwald says other researchers are also looking at ways people are exposed to pesticides. He says people commonly think of being exposed to pesticides through contaminated water or food. But he believes the most efficient means of exposure is through tiny airborne particles of pollen.

    Groenwald says some beneficial drugs are delivered as tiny particles, which are inhaled deep into the lungs.

    He says researchers found tiny bits of pollen carried on the wind carry with them a load of pesticide.

    "Frankly, if there is a link between pesticides and these diseases, I think the very fine pollen is the transport mechanism, and is in some cases you might say the smoking gun," he says.

    Groenwald says because there are relatively few competing airborne pollutants in the Red River Valley, it's a perfect place to study airborne pesticide pollution.

    Groenwald hopes to continue and expand the study over the next three years, depending on how much funding the research receives.

    Source: Minnesota Public Radio ©2006 (28/07/06)

    © Multiple Sclerosis Resource Centre

    Related Items
    Abnormal Liver Tests and MS
    AlphaB-crystallin
    Aluminium and Multiple Sclerosis
    Antagonist compounds
    Antibodies, B Cells,T-Cell Activation, Immune Response
    Apolipoprotein D
    Bacteria & MS
    Biomarkers and MicroRNA
    Blood tests
    Bone Marrow Cells and MS Treatment
    Bowmann-Birk Inhibitor Concentrate (BBIC)
    Brain Atrophy, Lesion Loads, White and Grey Matter
    Brain Inflammation
    Brain Iron Deposits
    Calcium Binding Proteins
    Cerebro-Spinal Fluid & Spinal Cord
    Chronic Cerebrospinal Venous Insufficiency (CCSVI)
    CRMP-2
    CXCL1, 7, 12
    Cytokines & Chemokines
    Dendritic Cells
    Estrogen Receptors
    Fibrinogen, Mac-1 and Microglia
    HDL
    HERV-Fc1
    Histamine and MS
    Hormones And MS Research
    Immunoglobulins
    Infections and Multiple Sclerosis Relapses
    Interleukin-1beta
    JAK-STAT inhibitors
    Kallikrein 6
    Lipids & MS
    Medical Imaging
    Mycoplasmas And Bacteria
    N-acetylglucosamine (GlcNAc) & Glucosamine
    Natural Interferon Beta
    Natural Killer Cells
    Nerve and Brain Cell Research
    Neurosteroids
    Olig 1 Gene Discovery
    Oligodendrocytes and Astrocytes
    PKC-theta
    Plasma Exchange
    Potential Viral Causes of MS
    Proteomics
    Recombinant Human Erythropoietin
    Regeneration Research
    RNA and RNAi
    Synthetic Small Molecules
    Technology
    Tetanus Vaccine and Possible MS Protection
    Tetramers
    The Blood Brain Barrier
    Tremors And MS
    Uric Acid
    Urinary Problems
    Vascular Function And MS
    Vision and MS


    Did you find this information useful? Would you like to comment on this page? Let us know what you think! We welcome all comments and feedback on any aspect of our website - please click here to contact us.